Bio-Rad Laboratories (BIO) Stock Statistics & Valuation Metrics

Bio-Rad Laboratories has a market cap or net worth of $6.89B. The enterprise value is $7.72B.

Bio-Rad Laboratories has 22,142,422 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bio-Rad Laboratories’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is 2.37%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Bio-Rad Laboratories had revenue of 2.57B and earned -1.84B in profits. Earnings per share was -65.36.

In the last 12 months, operating cash flow was 190.47M and capital expenditures -125.51M, giving a free cash flow of 64.96M billion.

Bio-Rad Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Bio-Rad Laboratories upcoming earnings date is Jul 31, 2025, After Close (Confirmed).

Bio-Rad Laboratories as a current ratio of 6.48, with Debt / Equity ratio of 20.50%

In the past 12 months, Bio-Rad Laboratories has paid -498.30M in taxes.

Bio-Rad Laboratories EV to EBITDA ratio is -4.83, with an EV/FCF ratio of 38.15.

Bio-Rad Laboratories has $1.66B in cash and marketable securities with $1.37B in debt, giving a net cash position of -$290.90M billion.

Gross margin is 53.50%, with operating margin of 10.48%, and net profit margin of -71.86%.

The average price target for Bio-Rad Laboratories is $323.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy